KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $416,469 | -20.7% | 2,463 | +1.7% | 0.00% | -50.0% |
Q2 2023 | $525,211 | -53.5% | 2,422 | -61.0% | 0.00% | -33.3% |
Q1 2023 | $1,128,529 | -14.7% | 6,213 | -7.7% | 0.00% | -40.0% |
Q4 2022 | $1,322,838 | -4.4% | 6,732 | +9.5% | 0.01% | 0.0% |
Q3 2022 | $1,384,000 | +107.5% | 6,150 | +16.5% | 0.01% | +150.0% |
Q2 2022 | $667,000 | -27.3% | 5,279 | -27.2% | 0.00% | 0.0% |
Q1 2022 | $918,000 | -22.3% | 7,248 | -19.6% | 0.00% | 0.0% |
Q4 2021 | $1,182,000 | +5.5% | 9,017 | -1.6% | 0.00% | -33.3% |
Q3 2021 | $1,120,000 | -11.1% | 9,159 | -17.1% | 0.00% | -25.0% |
Q2 2021 | $1,260,000 | +31.7% | 11,053 | +38.9% | 0.00% | +33.3% |
Q1 2021 | $957,000 | +23.3% | 7,960 | +4.2% | 0.00% | 0.0% |
Q4 2020 | $776,000 | +61.3% | 7,636 | +22.7% | 0.00% | +50.0% |
Q3 2020 | $481,000 | -31.3% | 6,223 | -0.9% | 0.00% | -50.0% |
Q2 2020 | $700,000 | +131.8% | 6,282 | +49.6% | 0.00% | +100.0% |
Q1 2020 | $302,000 | -35.9% | 4,199 | -32.8% | 0.00% | 0.0% |
Q4 2019 | $471,000 | – | 6,247 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |